Axsome Therapeutics, Inc. - COM (AXSM)

Historical Portfolio Holders from Q4 2015 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
37.1 M
Holdings value Q1 2024
$2.96 B
Value change Q1 2024
-$37.2 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
243
Number of buys Q1 2024
133
Number of sells Q1 2024
-97
Average buys Q1 2024 %
+0.063%
Average sells Q1 2024 %
-0.003%
CUSIP
05464T104
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 37.1 M $2.96 B -$37.2 M $79.80 243
2023 Q4 37.9 M $3.02 B -$11 M $79.59 237
2023 Q3 37.6 M $2.63 B +$88.1 M $69.89 223
2023 Q2 36.1 M $2.59 B +$316 M $71.86 227
2023 Q1 31.8 M $1.96 B +$94.6 M $61.68 195
2022 Q4 30 M $2.31 B +$390 M $77.13 209
2022 Q3 24.4 M $1.09 B +$177 M $44.62 177
2022 Q2 21 M $804 M +$86.6 M $38.30 165
2022 Q1 18.7 M $773 M +$21.6 M $41.39 162
2021 Q4 18.4 M $694 M -$17.6 M $37.78 157
2021 Q3 18.6 M $611 M -$186 M $32.96 161
2021 Q2 22.3 M $1.51 B -$37.4 M $67.46 170
2021 Q1 22.9 M $1.3 B -$60 M $56.62 181
2020 Q4 23.8 M $1.94 B -$4.08 M $81.47 172
2020 Q3 23.5 M $1.67 B -$20.4 M $71.25 163
2020 Q2 23.6 M $1.94 B +$153 M $82.28 185
2020 Q1 22.5 M $1.32 B +$44 M $58.83 156
2019 Q4 22.3 M $2.3 B +$376 M $103.36 167
2019 Q3 18.8 M $381 M +$9.02 M $20.24 108
2019 Q2 18.2 M $470 M +$100 M $25.75 102
2019 Q1 14.7 M $209 M +$159 M $14.23 61
2018 Q4 3.83 M $10.8 M +$479 K $2.82 35
2018 Q3 3.53 M $12.2 M -$1.99 M $3.45 32
2018 Q2 4.1 M $13.1 M -$306 K $3.20 34
2018 Q1 4.23 M $10.4 M -$6.12 M $2.45 35
2017 Q4 5.82 M $32.6 M -$1.05 M $5.60 33
2017 Q3 6.01 M $33.3 M -$2.14 M $5.55 26
2017 Q2 6.4 M $35.3 M -$6.15 M $5.50 33
2017 Q1 7.26 M $28.3 M +$5.38 M $3.90 46
2016 Q4 6.16 M $41.6 M -$1 M $6.75 40
2016 Q3 6.31 M $49.7 M +$4.02 M $7.88 36
2016 Q2 5.8 M $43.7 M +$3.93 M $7.54 34
2016 Q1 5.26 M $45.2 M +$313 K $8.60 17
2015 Q4 5.22 M $47.7 M +$47.7 M $9.25 11